Congressional Democrats put Trump's pharma stock at up to $56.2 million, 33 times its 2024 ceiling
Joint Economic Committee Democrats say Trump's pharma stock reached up to $56.2 million by the end of 2025, from up to $1.7 million in 2024. Up to $39.1 million of it is in drugmakers that benefited from Medicare negotiation exemptions, and the White House denies any conflict.
Reality
- Evidence45
- Adoption
- Not scored
- Hype gap+25
- Incentives70
- Confidence55
Joint Economic Committee finds Tinder's median scammer profile views rose over 700 percent
Congress's Joint Economic Committee found nearly 1.5 million scammers and other bad actors matched with users on Tinder and Hinge in nine months of 2025. Match Group says the report mischaracterizes its safety work.
Reality
- Evidence55
- Adoption50
- Hype gap+10
- Incentives60
- Confidence58
A congressional investigation lasting about a year found Tinder's scam detection struggled for years to keep fraudulent accounts off the app. Match Group has since added verification requirements and upgraded its detection technology.
Reality
- Evidence66
- Adoption
- Not scored
- Hype gap+5
- Incentives50
- Confidence70
Senators passed the Health Care Cybersecurity and Resilience Act by unanimous consent after the 2024 version died with its term. If the House agrees, healthcare's security rules get updated, with federal grants and training attached.
Reality
- Evidence60
- Adoption
- Not scored
- Hype gap+15
- Incentives50
- Confidence65
Bipartisan bills would put biomanufacturing and genomic data inside CISA's infrastructure planning
Five lawmakers announced two bills putting biotech and genomic data under CISA's infrastructure planning, with no new sector. If enacted, DHS would contact key biotech firms and fold their input into the National Infrastructure Protection Plan this year.
Reality
- Evidence55
- Adoption
- Not scored
- Hype gap+10
- Incentives40
- Confidence55